Minnie Sarwal
Directeur Général chez Nephrosant, Inc.
Profil
Minnie M.
Sarwal is the founder of Organ-I, Inc. founded in 2009 and Nephrosant, Inc. founded in 2017, where she currently holds the title of Chief Executive Officer.
Postes actifs de Minnie Sarwal
| Sociétés | Poste | Début |
|---|---|---|
Nephrosant, Inc.
 Nephrosant, Inc. BiotechnologyHealth Technology Nephrosant, Inc. is a company dedicated to improving kidney health through noninvasive diagnostic tests. The company is based in Brisbane, CA. The company's flagship diagnostic test is QSant, a noninvasive urine-based test that supports early detection of kidney rejection risk. Nephrosant plans to develop centralized lab tests and point of care tests for kidney diseases and allograft monitoring for other organs. Founded in 2017 by Dr. Minnie Sarwal and UCSF physicians, the company has a team of world-class scientists, engineers, and clinicians who have licensed the founding team's clinical research to develop diagnostic tests for chronic kidney disease. Dr. Sarwal has been the CEO since 2017. | Directeur Général | 01/11/2017 |
Anciens postes connus de Minnie Sarwal
| Sociétés | Poste | Fin |
|---|---|---|
Organ-I, Inc.
 Organ-I, Inc. Miscellaneous Commercial ServicesCommercial Services Organ-I, Inc. develops non invasive tests to monitor and predict organ health for transplant recipients. The company was founded by Steven Humphreys and Minnie M. Sarwal in 2009 is headquartered in Palo Alto, CA. | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Organ-I, Inc.
Organ-I, Inc. Miscellaneous Commercial ServicesCommercial Services Organ-I, Inc. develops non invasive tests to monitor and predict organ health for transplant recipients. The company was founded by Steven Humphreys and Minnie M. Sarwal in 2009 is headquartered in Palo Alto, CA. | Commercial Services |
Nephrosant, Inc.
Nephrosant, Inc. BiotechnologyHealth Technology Nephrosant, Inc. is a company dedicated to improving kidney health through noninvasive diagnostic tests. The company is based in Brisbane, CA. The company's flagship diagnostic test is QSant, a noninvasive urine-based test that supports early detection of kidney rejection risk. Nephrosant plans to develop centralized lab tests and point of care tests for kidney diseases and allograft monitoring for other organs. Founded in 2017 by Dr. Minnie Sarwal and UCSF physicians, the company has a team of world-class scientists, engineers, and clinicians who have licensed the founding team's clinical research to develop diagnostic tests for chronic kidney disease. Dr. Sarwal has been the CEO since 2017. | Health Technology |
